These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 22577589)

  • 61. Endogenous toll-like receptor ligands and their biological significance.
    Yu L; Wang L; Chen S
    J Cell Mol Med; 2010 Nov; 14(11):2592-603. PubMed ID: 20629986
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor.
    Vilahur G; Badimon L
    Front Physiol; 2014; 5():496. PubMed ID: 25566092
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.
    Waterman RS; Tomchuck SL; Henkle SL; Betancourt AM
    PLoS One; 2010 Apr; 5(4):e10088. PubMed ID: 20436665
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis.
    Khajeh Alizadeh Attar M; Anwar MA; Eskian M; Keshavarz-Fathi M; Choi S; Rezaei N
    Med Res Rev; 2018 Sep; 38(5):1469-1484. PubMed ID: 29283184
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Antiinfective host defense mechanism: toll-like receptors and innate immunity].
    Takesue Y; Ohge H; Kohyama M; Imamura Y; Murakami Y; Sueda T
    Nihon Geka Gakkai Zasshi; 2003 Jul; 104(7):494-8. PubMed ID: 12884772
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Role of Toll-Like Receptors in Hematopoietic Malignancies.
    Monlish DA; Bhatt ST; Schuettpelz LG
    Front Immunol; 2016; 7():390. PubMed ID: 27733853
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression of TRAF6 and pro-inflammatory cytokines through activation of TLR2, TLR4, NOD1, and NOD2 in human periodontal ligament fibroblasts.
    Tang L; Zhou XD; Wang Q; Zhang L; Wang Y; Li XY; Huang DM
    Arch Oral Biol; 2011 Oct; 56(10):1064-72. PubMed ID: 21457942
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals.
    Vidya MK; Kumar VG; Sejian V; Bagath M; Krishnan G; Bhatta R
    Int Rev Immunol; 2018 Jan; 37(1):20-36. PubMed ID: 29028369
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of statins on toll-like receptors: a new insight to pleiotropic effects.
    Bahrami A; Parsamanesh N; Atkin SL; Banach M; Sahebkar A
    Pharmacol Res; 2018 Sep; 135():230-238. PubMed ID: 30120976
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation.
    Goldstein DR; Palmer SM
    J Heart Lung Transplant; 2005 Nov; 24(11):1721-9. PubMed ID: 16297771
    [TBL] [Abstract][Full Text] [Related]  

  • 71. RAGE and TLRs: relatives, friends or neighbours?
    Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
    Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.
    Kawai T; Akira S
    Nat Immunol; 2010 May; 11(5):373-84. PubMed ID: 20404851
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Toll-like receptors are potential therapeutic targets in rheumatoid arthritis.
    Shotorbani SS; Su ZL; Xu HX
    World J Biol Chem; 2011 Jul; 2(7):167-72. PubMed ID: 21912729
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel drugs targeting Toll-like receptors for antiviral therapy.
    Patel MC; Shirey KA; Pletneva LM; Boukhvalova MS; Garzino-Demo A; Vogel SN; Blanco JC
    Future Virol; 2014 Sep; 9(9):811-829. PubMed ID: 25620999
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs.
    Olson JK; Miller SD
    J Immunol; 2004 Sep; 173(6):3916-24. PubMed ID: 15356140
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
    De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Toll-like receptors: a family of pattern-recognition receptors in mammals.
    Armant MA; Fenton MJ
    Genome Biol; 2002 Jul; 3(8):REVIEWS3011. PubMed ID: 12186654
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
    Ma Z; Zhang E; Yang D; Lu M
    Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injury.
    Wang Y; Abarbanell AM; Herrmann JL; Weil BR; Poynter J; Manukyan MC; Crisostomo PR; Meldrum DR
    Shock; 2010 Dec; 34(6):548-57. PubMed ID: 20458266
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Toll-like receptors: sensor molecules for detecting damage to the nervous system.
    Lee H; Lee S; Cho IH; Lee SJ
    Curr Protein Pept Sci; 2013 Feb; 14(1):33-42. PubMed ID: 23441900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.